by RCGP eLearning Podcast
The Royal College of General Practitioners is the professional membership body for family doctors in the UK and overseas. This podcast is produced by the RCGP eLearning and Essential Knowledge Update teams and features discussions with clinical experts about a range of key topics in primary care.
Language
🇺🇲
Publishing Since
10/26/2015
Email Addresses
1 available
Phone Numbers
0 available
April 23, 2025
<div>People living with severe mental illness face one of the greatest health equality gaps in England. Their life expectancy is 15–20 years shorter than that for the general population, and this disparity is largely due to preventable physical illnesses.</div> <br> <div>In this podcast, Dr Thomas Round discusses physical health in people with severe mental illness with Professor Carolyn Chew-Graham, a Professor of General Practice Research at Keele University and a GP in Manchester and Dr David Shiers, Honorary Research Consultant at Psychosis Research Unit and<strong> </strong>a former GP in North Staffordshire, who became involved in the early intervention reform after his daughter’s experience of a severe psychotic illness. </div>
February 20, 2025
<div>In this podcast Dr. Julie Oliver, chair of the Primary Care Women’s Health Society is interviewed about endometriosis. Starting with the basics of definition and symptoms, the podcast then goes on to discuss more nuanced aspects of care, including decisions about whether to refer or manage empirically, and how to support a patient in primary care while she is on a potentially long list for consultant review. The podcast takes a life course approach, ending with a discussion about management of the menopause in women who have had endometriosis, and the need to remember that symptoms may persist even after apparently definitive surgical treatment. <br> <br> An educational grant was received from Scottish Government for the production of this podcast. Editorial and content decisions were made solely by the RCGP.<br> <br> </div>
February 6, 2025
<div>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs initially developed to treat type 2 diabetes and are now becoming more widely used for obesity. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating. GPs will be used to prescribing them for type 2 diabetes, but less so for obesity. </div> <br> <div>In this podcast, Dr Thomas Round discusses the evolving role of GLP1-RA in obesity, the benefits and potential side effects, the role of the GP, and the latest NICE guidance in this area with Dr Stephanie DiGiorgio, an urgent care GP with a specialist interest in obesity. </div>
GPnotebook
NB Medical Education
Primary Care Knowledge Boost
Red Whale
BMJ Group
The BMJ
Dr Rachel Morris
Medics Money
The Good GP
Thomas Watchman
Simon Laing, Rob Fenwick & James Yates
ZOE
GPonline.com
BBC News
Elizabeth Day and Sony Music Entertainment
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.